Abiopharma

🔍 Ribeiro Ramiro (Executive)

Company: EyePoint, Inc. (EYPT)

Report Date: 2026-01-05

Detailed Transactions and Holdings:

• Acquired 29,250 shares of Common Stock at $8.26 per share (Direct)
  Date: 2026-01-05 | Code: M | equity_swap_involved: false | shares_owned_after: 42,544.00 | transaction_form_type: 4
• Sold 42,544 shares of Common Stock at $17.0957 per share (Direct)
  Date: 2026-01-05 | Code: S | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F1
• Sold 29,250 shares of Stock Option (Right to Buy) at $8.26 per share (Derivative)
  Date: 2026-01-05 | Code: M | Expires: 2035-01-03 | equity_swap_involved: false | shares_owned_after: 87,750.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.68 to $17.51. The reporting person undertakes to provide EyePoint Inc., any security holder of EyePoint Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F2: The option to purchase will vest and become exercisable as follows: 25% at January 3, 2026 and the remainder ratably, on a monthly basis, over the remaining three years.